×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SHILPA MEDICARE LTD. | 3,204.48 | 317.84 | 3,193.16 | 3.25 | 6,601 | 78.0 |
| FDC LTD. | 4775.07 | 364.47 | 4588.62 | 2.24 | 6572 | 24.0 |
| STRIDES PHARMA SCIENCE LIMITED | 5533.45 | 149.38 | 5509.17 | 1.62 | 6009 | 24.1 |
Shilpa Medicare Ltd., with Security Code 530549, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 60.8 | 68.7 | 51.6 | 66.4 | 83.7 | 74.6 | 63.9 | 87.4 | 96.1 | 129.6 |
| Expenses | 56.3 | 93.2 | 61.9 | 80.3 | 68.4 | 67.3 | 67.3 | 80.5 | 72.2 | 86.8 |
| Operating Profit | 4.5 | -24.5 | -10.3 | -13.8 | 15.3 | 7.3 | -3.3 | 7.0 | 23.9 | 42.9 |
| OPM % | 7.4% | -35.61% | -19.86% | -20.71% | 18.32% | 9.77% | -5.15% | 7.96% | 24.91% | 33.05% |
| Other Income | 12.6 | 17.5 | 17.6 | 5.4 | 14.4 | 22.5 | 22.2 | 19.5 | 31.0 | 21.0 |
| Interest | 2.7 | 4.9 | 6.6 | 6.6 | 6.8 | 5.2 | 2.6 | 2.7 | 1.9 | 1.2 |
| Depreciation | 10.4 | 11.9 | 12.3 | 12.0 | 12.3 | 12.7 | 12.4 | 12.3 | 12.3 | 12.0 |
| Profit before tax | 4.1 | -23.2 | -11.6 | -12.0 | 17.1 | 12.2 | 4.0 | 15.2 | 41.2 | 51.1 |
| Tax % | 4.8% | -17.5% | -58.6% | -7.2% | 26.6% | 45% | 31% | 14.8% | 30.3% | 39.8% |
| Net Profit | 108.1 | -17.2 | -4.8 | -28.9 | 7.9 | 6.6 | 2.7 | 9.7 | 28.3 | 30.5 |
| EPS in Rs | 12.45 | -1.98 | -0.55 | -3.33 | 0.91 | 0.76 | 0.31 | 1.12 | 2.94 | 3.12 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 262.9 | 262.5 | 263.6 | 260.2 | 313.0 | 286.5 | 291.7 | 292.5 | 343.8 | 319.3 |
| Expenses | 252.9 | 231.2 | 226.5 | 213.9 | 254.6 | 221.6 | 221.8 | 222.4 | 258.2 | 238.6 |
| Operating Profit | 10.0 | 31.3 | 37.0 | 46.3 | 58.4 | 64.9 | 69.9 | 70.1 | 85.6 | 80.7 |
| OPM % | 3.8% | 11.9% | 14.1% | 17.8% | 18.7% | 22.6% | 24% | 24% | 24.9% | 25.3% |
| Other Income | 4.4 | 2.7 | 2.2 | 1.9 | 1.8 | 2.2 | 8.6 | 9.4 | 5.0 | 1.1 |
| Interest | 13.5 | 17.9 | 17.7 | 18.2 | 23.2 | 26.2 | 24.2 | 23.7 | 25.6 | 11.7 |
| Depreciation | 23.3 | 24.1 | 25.7 | 26.7 | 27.8 | 26.7 | 26.6 | 27.1 | 28.3 | 28.8 |
| Profit before tax | -22.4 | -7.9 | -4.2 | 3.3 | 9.2 | 14.2 | 21.6 | 28.7 | 36.8 | 41.3 |
| Tax % | -18.9% | -12.1% | -126% | 42.7% | 68.6% | 62.1% | 11.5% | 45.4% | 50.7% | 23.8% |
| Net Profit | -18.6 | -6.6 | -8.0 | 1.2 | 1.6 | 4.7 | 24.5 | 14.1 | 17.9 | 31.8 |
| EPS in Rs | -2 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 3 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -14% |
| 3 Years: | 6% |
| TTM: | 69% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -22% |
| 3 Years: | -37% |
| TTM: | 258% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 8% |
| 3 Years: | 15% |
| 1 Year: | 50% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -20% |
| 3 Years: | -33% |
| TTM: | 12021% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 8% |
| 3 Years: | 15% |
| 1 Year: | 50% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|